首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1705631

全球多重分析市場按產品、類型、技術、應用、最終用戶和地區分類

Global Multiplex Assay Market, By Product, By Type, By Technology, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球多重檢測市場規模為 17 億美元，到 2032 年將達到 44.5 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 14.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	17億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	14.70%	2032年價值預測	44.5億美元

數字。 2025年全球市場佔有率（%）

近年來，受全球慢性病和感染疾病率上升的推動，多重檢測市場經歷了顯著成長。多重分析允許在單次分析中同時檢測多種分析物，從而提高診斷準確性和吞吐量。這使得實驗室能夠簡化測試流程，同時最大限度地降低營運成本。包括微陣列和以微珠為基礎的技術在內的各種技術進步促進了高通量連接複用平台的開發，該平台具有高靈敏度和特異性，可用於臨床診斷和研究應用。展望未來，易患與老齡化相關的疾病的老年人口的增加、診斷測試的醫療支出的增加以及精準醫療的擴展預計將為多重檢測市場中的公司提供豐厚的機會。

市場動態：

多重檢測市場受到個人化醫療需求不斷成長、蛋白質組學和基因組學領域研發活動強勁以及多重檢測在生物標記研究和臨床診斷中的應用不斷擴大等因素的推動。然而，複雜的檢測開發和嚴格的法律規範帶來了限制市場成長的挑戰。微射流和數位 PCR 技術的發展促進了高通量、低樣本量、可攜式連接複用平台的開發，創造了新的機會。缺乏熟練的專業人才和高成本也在一定程度上對市場擴張構成挑戰。

多重檢測技術的日益普及是市場發展的關鍵驅動力。多重分析允許在單一實驗中同時分析多個目標，因此與傳統的單重分析相比具有許多優勢。多重分析具有透過多種方式推動市場成長的潛力，包括能夠同時測試多種分析物，從而節省實施的時間和精力。透過整合測試，多重檢測可以降低與試劑、消耗品和實驗室開銷相關的整體成本。多重分析非常適合高通量篩檢，並且可用於大規模研究和臨床診斷。連接複用技術可以分析有限的樣本量，從而保存切片檢查和稀有細胞群等珍貴樣本。

例如，2021 年 6 月，食品、環境、藥品和化妝品檢測領域的全球領導者 Eurofins 宣布推出 GSD NovaType III SARS-CoV-2 RT-PCR 檢測，該檢測旨在快速檢測 SARS-CoV-2 變體。此檢測可在單一反應中識別相關突變 E484Q、E484K 和 L452R，同時便於將它們與 S 基因 E484 野生型變異區區分開來。

研究的主要特點

本報告對全球多重檢測市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球多重檢測市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球多重分析市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球多重分析市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.70%	2032 Value Projection:	USD 4.45 Bn

The multiplex assay market has been witnessing significant growth in the recent past on account of the rising incidence of chronic and infectious diseases globally. Multiplexing permits simultaneous detection of multiple analytes in a single assay run, which enhances diagnostic accuracy and throughput. It allows laboratories to streamline testing processes while minimizing operational costs. Various technological advancements including microarrays and bead-based techniques have facilitated the development of high-throughput multiplex platforms with high sensitivity and specificity for clinical diagnostics and research applications. Going forward, the growing geriatric population vulnerable to age-related illnesses, increasing healthcare expenditures on diagnostic testing, and expansion of precision medicine are expected to present lucrative opportunities for players in the multiplex assay market.

Market Dynamics:

The multiplex assay market is driven by factors such as growing demand for personalized medicine, robust R&D activity in the field of proteomics and genomics, and increasing applications of multiplex assays in biomarker research and clinical diagnostics. However, complexity of assay development and stringent regulatory framework are some challenges restraining the market growth. Adoption of microfluidics and digital PCR technologies create new opportunities by facilitating development of high-throughput, low sample volume, and portable multiplex platforms. Lack of skilled experts and high cost of instruments also challenge market expansion to some extent.

The growing adoption of multiplex assay techniques is a significant driver for the market. Multiplex assays offer numerous advantages over traditional singleplex assays by allowing the simultaneous analysis of multiple targets in a single experiment, which can drive the market growth in several ways such as multiplex assays can test for multiple analytes at once, saving time and labor compared to running. By consolidating tests, multiplex assays can reduce overall costs associated with reagents and consumables, as well as laboratory overhead. They are ideal for high-throughput screening, making them valuable in large-scale studies and clinical diagnostics. Multiplexing enables analysis from limited sample volumes, preserving precious samples like biopsy material or rare populations of cells.

For instance, in June 2021, Eurofins, the global leader in food, environment, pharmaceutical, and cosmetic product testing, announced the launch of GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 variants. The assay facilitates the identification of the relevant mutations E484Q, E484K, and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 wildtype variant.

Key Features of the Study:

This report provides an in-depth analysis of the global multiplex assay market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global multiplex assay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen, Abcam Plc., Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, MESO SCALE DIAGNOSTICS, LLC., Randox Laboratories Ltd., Seegene Inc, Perkin Elmer Inc., R&D Systems, Inc., and Advanced Cell Diagnostics, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global multiplex assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplex assay market

Detailed Segmentation:

By Product
- Consumables
- Instruments
- Software
By Type
- Protein Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Nucleic Acid Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Cell-based Multiplex Assays
By Technology
- Flow Cytometry
- Fluorescence Detection
- Luminescence
- Multiplex Real-time PCR
- Other Technologies
By Application
- Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
- Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases
By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic laboratories
- Research & Academic Institutes
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen
- Abcam Plc.
- Becton, Dickinson and Company
- Merck KGaA
- Agilent Technologies
- MESO SCALE DIAGNOSTICS, LLC.
- Randox Laboratories Ltd.
- Seegene Inc
- Perkin Elmer Inc.
- R&D Systems, Inc.
- Advanced Cell Diagnostics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Multiplex Assay Market, By Product
- Multiplex Assay Market, By Type
- Multiplex Assay Market, By Technology
- Multiplex Assay Market, By Application
- Multiplex Assay Market, By End User
- Multiplex Assay Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
- Advancing genomics and proteomics research
- Increasing focus on precision medicine
- Increasing product launches
Restraints
Opportunity
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Multiplex Assay Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Multiplex Assay Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Protein Multiplex Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Planar Protein Assays
Bead-based Protein Assays
Nucleic Acid Multiplex Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Planar Protein Assays
Bead-based Protein Assays
Cell-based Multiplex Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Multiplex Assay Market, By Technology, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Fluorescence Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Luminescence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Multiplex Real-time PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Multiplex Assay Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Research & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Drug Discovery & Development
Biomarker Discovery & Validation
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infectious Diseases
Cancer
Cardiovascular Diseases
Autoimmune Diseases
Nervous System Disorders
Metabolism & Endocrinology Disorders
Other Diseases

9. Global Multiplex Assay Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospitals & Diagnostic laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other End Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Global Multiplex Assay Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
Asia Pacific
Latin America
Middle East
Africa

11. Competitive Landscape

Luminex Corporation
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Qiagen
Abcam Plc.
Becton, Dickinson and Company
Merck KGaA
Agilent Technologies
MESO SCALE DIAGNOSTICS, LLC.
Randox Laboratories Ltd.
Seegene Inc
Perkin Elmer Inc.
R&D Systems, Inc.
Advanced Cell Diagnostics, Inc.
Analyst Views